Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
about
Pancreatic stellate cell: Pandora's box for pancreatic disease biology.Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.Decreased carbonyl reductase 1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas.Claudin1 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells by upregulating the expression and nuclear entry of β-catenin
P2860
Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@en
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@nl
type
label
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@en
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@nl
prefLabel
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@en
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@nl
P2093
P2860
P1476
Oridonin inhibits pancreatic c ...... t/β-catenin signaling pathway.
@en
P2093
P2860
P2888
P356
10.1186/S12935-016-0336-Z
P577
2016-07-22T00:00:00Z
P6179
1047458751